EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity



Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity



Farmaco 59(3): 185-194



Fourteen out of 21 quinoxaline derivatives described in the present paper were selected at NCI for evaluation of their in vitro anticancer activity. Preliminary screening showed that some derivatives exhibited a moderate to strong growth inhibition activity on various tumor panel cell lines between 10(-5) and 10(-4) M concentrations. Interesting selectivities were also recorded between 10(-8) and 10(-6) M for the compounds 9 and 13.

(PDF emailed within 0-6 h: $19.90)

Accession: 050094724

Download citation: RISBibTeXText

PMID: 14987981

DOI: 10.1016/j.farmac.2003.11.014



Related references

Quinoxaline chemistry. Part XVII. Methyl (4-(substituted 2-quinoxalinyloxy) phenyl) acetates and ethyl N-((4-(substituted 2-quinoxalinyloxy) phenyl) acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity. Farmaco (Lausanne) 59(3): 185-194, 2004

Quinoxaline chemistry. Part 11. 3-Phenyl-2[phenoxy- and phenoxymethyl]-6(7) or 6,8-substituted quinoxalines and N-[4-(6(7)-substituted or 6,8-disubstituted-3-phenylquinoxalin-2-yl)hydroxy or hydroxymethyl] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase. Farmaco 53(7): 480-493, 1998

Quinoxaline chemistry. Part 11. 3-Phenyl-2 (phenoxy- and phenoxymethyl)-6(7) or 6,8-substituted quinoxalines and N-(4-(6(7)-substituted or 6,8-disubstituted-3-phenylquinoxalin-2-yl)hydroxy or hydroxymethyl) benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase. Farmaco (Lausanne) 53(7): 480-493, 1998

Quinoxaline chemistry Part XVII Methyl phenyl acetates and ethyl N-. Farmaco (Lausanne) 59(3): 185-194, March, 2004

Quinoxaline chemistry Part 13 3-carboxy-2-benzylamino-substituted quinoxalines and N- aminomethylbenzoyl-L-glutamates Synthesis and evaluation of in vitro anticancer activity. Farmaco (Lausanne) 55(2): 77-86, 2000

Quinoxaline chemistry. Part 13: 3-Carboxy-2-benzylamino-substituted quinoxalines and N-[4-[(3-carboxyquinoxalin-2-yl) aminomethyl]benzoyl]-L-glutamates: synthesis and evaluation of in vitro anticancer activity. Farmaco 55(2): 77-86, 2000

Quinoxaline chemistry. Part 13: 3-carboxy-2-benzylamino-substituted quinoxalines and N-(4-((3-carboxyquinoxalin-2-yl) aminomethyl)benzoyl)-L-glutamates: Synthesis and evaluation of in vitro anticancer activity. Farmaco (Lausanne) 55(2): 77-86, 2000

Quinoxaline chemistry Part 11 3-Phenyl-2 -6 or 6,8-substituted quinoxalines and N- hydroxy or hydroxymethyl benzoylglutamates Synthesis and evaluation of in vitro anticancer activity and enzymatic inhibitory activity against dihydrofolate reductase and thymidylate synthase. Farmaco (Lausanne) 53(7): 480-493, July 30, 1998

Quinoxaline chemistry Part 16 4-Substituted anilino and 4-substituted phenoxymethyl pyrrolo quinoxalines and N- amino and hydroxymethylbenzoyl glutamates Synthesis and evaluation of in vitro biological activity. Farmaco (Lausanne) 58(9): 639-650, September, 2003

Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity. Farmaco 58(9): 639-650, 2003

Quinoxaline chemistry. Part 16. 4-Substituted anilino and 4-substituted phenoxymethyl pyrrolo(1,2-a)quinoxalines and N-(4-(pyrrolo(1,2-a)quinoxalin-4-yl)amino and hydroxymethyl)benzoyl glutamates. Synthesis and evaluation of in vitro biological activity. Farmaco (Lausanne) 58(9): 639-650, 2003

Quinoxaline chemistry: Part 12. 3-carboxy-2(phenoxy)-6(7)substituted quinoxalines and N-(4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy) benzoylglutamates: Synthesis and evaluation of in vitro anticancer activity. Farmaco (Lausanne) 53(8-9): 594-601, 1998

Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity. Farmaco 53(8-9): 594-601, 1999

Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity. Medicinal Chemistry ) 7(6): 605-610, 2012

Synthesis and in-vitro antifungal activity of 6-substituted-phenyl-2- {[(4'-substituted phenyl-5'-thioxo)-1,2,4-triazol-3-yl]-methyl}-2,3,4,5-tetrahydropyridazin-3-one derivatives. Acta Poloniae Pharmaceutica 65(2): 223-228, 2008